CONRAD GMP CICCR Feasibility Project Funding Very limited Available Available Phase III Clinical Studies for Effectiveness Supported Supported Not Supported Funding of For-Profit Entities Possible Possible No Country Limitations Must be eligible for U.S. population assistance* None None Industry Collaboration Not required Desirable High priority Facilities & Administrative Costs Up to 15% of direct costs Up to 15% of direct costs for subproject agreements** Not provided * Ineligible countries include Afghanistan, Cambodia, Cuba, Iran, Iraq, Laos, Libya, North Korea, People's Republic of China, Syria, and Vietnam. **   F&A costs are not provided for GMP fixed-cost service contracts.